ENGEL; Sharon

Patent Applications and Registrations

Patent applications and USPTO patent grants for ENGEL; Sharon.The latest application filed is for "fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disorders".

Company Profile

1.4.7

ENGEL; Sharon - Hudson MA
Engel, Sharon - Ramat Hasharon IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders App 20210300942 - CHYTIL; Milan ; et al.	2021-09-30
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders App 20200024286 - CHYTIL; Milan ; et al.	2020-01-23
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders App 20180057506 - CHYTIL; Milan ; et al.	2018-03-01
Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders Grant 9,758,529 - Chytil , et al. September 12, 2	2017-09-12
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders App 20160264597 - Chytil; Milan ; et al.	2016-09-15
Alternative splice variants App 20040258681 - Savitzky, Kinneret ; et al.	2004-12-23
VEGF nucleic acid and amino acid sequences Grant 6,783,954 - Mintz , et al. August 31, 2	2004-08-31
Alternative splice variants of CD40 Grant 6,720,182 - Savitzky , et al. April 13, 2	2004-04-13
Novel nucleic acid and amino acid sequences App 20030125295 - Mintz, Liat ; et al.	2003-07-03
Variant of vascular endothelial growth factor Grant 6,506,884 - Mintz , et al. January 14, 2	2003-01-14
Novel nucleic acid and amino acid sequences App 20020103149 - Mintz, Liat ; et al.	2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.